TY - JOUR T1 - Pinna-Imitating Microphone Directionality Improves Sound Localization and Discrimination in Bilateral Cochlear Implant Users JF - medRxiv DO - 10.1101/2020.03.05.20023937 SP - 2020.03.05.20023937 AU - Tim Fischer AU - Christoph Schmid AU - Martin Kompis AU - Georgios Mantokoudis AU - Marco Caversaccio AU - Wilhelm Wimmer Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/03/06/2020.03.05.20023937.abstract N2 - Objectives To compare the sound-source localization, discrimination and tracking performance of bilateral cochlear implant users with omnidirectional (OMNI) and pinnaimitating (PI) microphone directionality modes.Design Twelve experienced bilateral cochlear implant users participated in the study. Their audio processors were fitted with two different programs featuring either the OMNI or PI mode. Each subject performed static and dynamic sound field spatial hearing tests in the horizontal plane. The static tests consisted of an absolute sound localization test and a minimum audible angle (MAA) test, which was measured at 8 azimuth directions. Dynamic sound tracking ability was evaluated by the subject correctly indicating the direction of a moving stimulus along two circular paths around the subject.Results PI mode led to statistically significant sound localization and discrimination improvements. For static sound localization, the greatest benefit was a reduction in the number of front-back confusions (FBCs). The FBC score was reduced from 27% with OMNI mode to 18% with PI mode (p = 0.01). The ability to discriminate sound sources at the sides was only possible with PI mode. The MAA value for the sides decreased from a 75.5 to a 37.7-degree angle when PI mode was used (p < 0.001). Furthermore, the tracking of sound sources improved for both tested trajectories, but not significantly.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialKEK-BE, No. 2018-00901Funding StatementThis study was in part funded by the Med-El Corporation, the Berne University Research Foundation and the Fondation Charidu.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data referred to in this data is available as supplementary digital content. ER -